Chlamydial lipopolysaccharide

Journal of Endotoxin Research

Volumn 4, Issue 1, 1997, Pages 67-84

  Brade, H ^a   Brabetz, W ^a   Brade, L ^a   Holst, O ^a   Lobau S ^a,c   Lucakova, M ^a,d   Mamat, U ^a   Rozalski, A ^a,e   Zych, K ^a,e   Kosma, P ^b  

^a RESEARCH CENTER BORSTEL   (Germany)

^b UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d INSTITUTE OF VIROLOGY   (Slovakia)

^e UNIVERSITY OF LODZ   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOLIPID; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY;

BIOSYNTHESIS; CHEMICAL STRUCTURE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; NONHUMAN; REVIEW;

CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE;

EID: 12644310316     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1177/096805199700400108     Document Type: Review

References (113)

1. Schachter J., Caidwell H.D. Chlamydiae. Annu Rev Microbiol 1980; 34: 285-309.
2. Storz J. Chlamydia and chlamydia-induced diseases. Springfield, IL, USA: Charles C. Thomas, 1991.
3. Caldwell H.D., Kromhout J., Schachter J. Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun 1981; 31: 1161-1176.
4. Newhall W.J., Terho V.P., Wilde III C.E. et al. Serovar determination of Chlamydia trachomatis isolates using type-specific monoclonal antibodies. J Clin Microbiol 1986; 23: 333-338.
5. Stephens R.S., Tam M.R., Kuo C. et al. Monoclonal antibodies to Chlamydia trachomatis: antibody specificities and antigen characterization. J Immunol 1982; 128: 1083-1089.
6. Wang S.P., Barnes R.C., Stephens R.S. et al. Immunotyping of Chlamydia trachomatis with monoclonal antibodies. J Infect Dis 1985; 152: 791-800.
7. Allan I., Cunningham T.M., Lovett M. Molecular cloning of the of the major outer membrane protein of Chlamydia trachomatis. Infect Immun 1984; 45: 637-641.
8. Baehr W., Zhang Y., Joseph T. et al. Mapping antigenic domains expressed by Chlamydia trachomatis major outer membrane protein genes. Proc Natl Acad Sci USA 1988; 85: 4000-4004.
9. Stephens R.S., Kuo C-C., Newport G. et al. Molecular cloning and expression of Chlamydia trachomatis major outer membrane protein antigens in E. coli. Infect Immun 1985; 47: 713-718.
10. Schachter J., Dawson C.R. The epidemiology of trachoma predicts more blindness in the future. Scand J Infect Dis 1990; 69 (Suppl.): 55-62.
11. Grayston J.T., Kuo C-C., Wang S-P. et al. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med 1986; 315: 161-168.
12. Grayston J.T., Aldous M.B., Easton A. et al. Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis. J Infect Dis 1993; 168: 1231-1235.
13. Dalhoff K., Maass M. Chlamydia pneumoniae pneumonia in hospitalized patients - clinical characteristics and diagnostic value of polymerase chain reaction detection in BAL. Chest 1996; 110: 351-356.
14. Kuo C.C., Jackson L.A., Campbell L.A., Grayston J.T. Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 1995; 8: 451-461.
15. Grayston J.T. Chlamydia pneumoniae (TWAR) infections in children. Pediatr Infect Dis J 1994; 13: 675-685.
16. Barenfanger J., MacDonald A.B. The role of immunoglobulin in the neutralization of trachoma infectivity. J Immunol 1974; 113: 1607-1617.
17. Zhang Y-X., Stewart S., Joseph T. et al. Protective monoclonal antibodies recognize epitopes located on the major outer membrane protein of Chlamydia trachomatis. J Immunol 1987; 138: 575-581.
18. Grayston J.T., Wang S-P., Yeh L-S. et al. Importance of reinfection in the pathogenesis of trachoma. Rev Infect Dis 1985; 7: 717-725.
19. Watkins N.G, Hadlow W.J., Moss A.B. et al. Ocular delayed hypersensitivity: a pathogenic mechanism of chlamydial conjunctivitis in guinea pigs. Proc Natl Acad Sci USA 1986; 83: 7480-7484.
20. Morrison R.P., Belland R.J., Lyng K. et al. Chlamydial disease pathogenesis. The 57-kD chlamydial hypersensitivity antigen is a stress response protein. J Exp Med 1989; 170: 1271-1283.
21. Morrison R.P., Lyng K., Caldwell H.D. Chlamydial disease pathogenesis. Ocular hypersensitivity elicited by a genus-specific 57-kD protein. J Exp Med 1989; 169: 663-675.
22. Toye B., Laferrière C., Claman P. et al. Association between antibody to the chlamydial heat-shock protein and tubal infertility. J Infect Dis 1993; 168: 1236-1240.
23. Hahn D.L., Dodge R.W., Golubjatnikov R. Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma. JAMA 1991; 266: 225-230.
24. Sieper J., Braun J., Brandt J. et al. Pathogenic role of Chlamydia, Yersinia, amd Borrelia in undifferentiated oligoarthritis. J Rheumatol 1992; 19: 1236-1242.
25. Keat A., Thomas B.J., Dixey J. et al. Chlamydia trachomatis and reactive arthritis: the missing link. Lancet 1983; 1: 72-74.
26. Keat A., Thomas B.J., Taylor-Robinson D. Chlamydial infection in the aetiology of arthritis. Br Med Bull 1983; 39: 168-174.
27. Rietschel E.T., Kirikae T., Schade F.U. et al. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J 1994; 8: 217-225.
28. Ulevitch R.J., Tobias P.S. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol 1995; 13: 437-457.
29. Saikku P., Mattila K., Nieminen M.S. et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease. Lancet 1988; 2: 983-986.
30. Linnanmäki E., Leinonen M., Mattila K. et al. Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease. Circulation 1993; 87: 1130-1134.
31. Kuo C., Gown A.M., Benditt E.P. et al. Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Arterioscler Thromb 1993; 13: 1501-1504.
32. Kuo C-C., Shor A., Campbell L.A. et al. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 1993; 167: 841-849.
33. Campbell L.A., Moazed T.C., Kuo C-C., Grayston J.T. Mouse models of atherosclerosis and Chlamydia pneumoniae infection. In: Stary A. Ed. Proceedings Third Meeting of the European Society for Chlamydia Research Bologna, Italy: Societa Editrice Esculapio 1996: 106.
34. Moulder J.W. Interaction of Chlamydiae and host cells in vitro. Microbiol Rev 1991; 55: 143-190.
35. Kuo C-C., Grayston J.T., Campbell L.A., Goo Y.A., Wissler R.W., Benditt E.P. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc Natl Acad Sci USA 1995; 92: 6911-6914.
36. Kingsbury D.T., Weiss E. Lack of deoxyribonucleic acid homology between species of the genus Chlamydia. J Bacteriol 1968; 96: 1421-1423.
37. Gaydos C.A., Palmer L., Quinn T.C. et al. Phylogenetic relationship of Chlamydia pneumoniae to Chlamydia psittaci and Chlamydia trachomatis as determined by analysis of 16S ribosomal DNA sequences. Int J Syst Bacteriol 1993; 43: 610-612.
38. Weissburg W.G. Polyphyletic origin of bacterial parasites. In: Moulder J.W. Ed. Intracellular parasitism. Boca Raton, FL, USA: CRC Press, 1989; 1-16.
39. Raulston J.E. Chlamydial envelope components and pathogen-host cell interactions. Mol Microbiol 1995; 15: 607-616.
40. Hatch T.P. Disulfide cross-linked envelope proteins: the functional equivalent of peptidoglycan in chlamydiae? J Bacteriol 1996; 178: 1-5.
41. Barbour A.G., Amato K.I., Hackstadt T. et al. Chlamydia trachomatis has penicillin-binding proteins but not detectable muramic acid. J Bacteriol 1982; 151: 420-428.
42. Zhang J.P., Stephens R.S. Mechanism of C. trachomatis attachment to eukaryotic host cells. Cell 1992; 69: 861-869.
43. Matsumoto A., Manire G.P. Electron microscopic observations on the effect of penicillin on the morphology of Chlamydia psittaci. J Bacteriol 1970; 101: 278-285.
44. Byrne G.I., Lehmann L.K., Landry G.J. Induction of tryptophane catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells. Infect Immun 1986; 53: 347-351.
45. Shemer-Avni Y., Wallach D., Sarov I. Inhibition of Chlamydia trachomatis growth by recombinant tumor necrosis factor. Infect Immun 1988; 56: 2503-2506.
46. Stephens R.S. Chlamydial genomic sequencing and manipulation. In: Stary A. Ed. Proceedings Third Meeting of the European Society for Chlamydia Research Bologna, Italy: Societa Editrice Esculapio, 1996; 7-10.
47. Richmond S.J., Stirling P., Ashley C.R. Virus infecting the reticulate bodies of an avian strain of Chlamydia psittaci. FEMS Microbiol Lett 1982; 14: 31-36.
48. Palmer L, Falkow S. A common plasmid of Chlamydia trachomatis. Plasmid 1986; 16: 62.
49. Wenman W.M., Lovett M.A. Expression in E. coli of Chlamydia trachomatis antigen recognized during human infection. Nature 1982; 269: 68-70.
50. Bedson S.P. Observations bearing on the antigenic composition of psittacosis virus. Br J Exp Pathol 1936; 17: 109-121.
51. Dhir S.P., Hakomori S., Kenny G.E. et al. Immunochemical studies on chlamydial group antigen (presence of a 2-keto-3-deoxycarbohydrate as immunodominant group). J Immunol 1972; 109: 116-122.
52. Nurminen M, Leinonen M., Saikku P. et al. The genus-specific antigen of Chlamydia: resemblance to the lipopolysaccharide of enteric bacteria. Science 1993; 220: 1279-1281.
53. Brade H., Brunner H. Serological cross-reactions between Acinetobacter calcoaceticus and Chlamydiae. J Clin Microbiol 1979; 10: 819-822.
54. Matthiesen M. Studies on ornithosis-related antigen from Bacterium anitratum. Bacterium anitratum and its ability to produce the omithosis-related antigen. Acta Pathol Microbiol Scand 1957; 41: 247-256.
55. Matthiesen M., Volkert M. The antigenic relationship between omithosis virus and Bacterium anitratum. Acta Pathol Microbiol Scand 1957; 41: 135-143.
56. Volkert M, Matthiesen M. An ornithosis related antigen from a coccoid bacterium. Acta Pathol Microbiol Scand 1956; 39: 117-126.
57. Brade H., Brunner H. Detection of chlamydial inclusion bodies with antisera to Acinetobacter calcoaceticus subsp. anitratus by indirect immunofluorescence. Infection 1980; 8: 215-216.
58. Nurminen M., Rietschel E.T., Brade H. Chemical characterization of Chlamydia trachomatis lipopolysaccharide. Infect Immun 1985; 48: 573-575.
59. Brade L., Schramek S., Schade U. et al. Chemical, biological, and immunochemical properties of the lipopolysaccharide of Chlamydia psittaci. Infect Immun 1986; 54: 568-574.
60. Brade L., Nurminen M., Mäkelä P.H. et al. Antigenic properties of Chlamydia trachomatis lipopolysaccharide. Infect Immun 1985; 48: 569-572.
61. Kühn H-M., Brade L., Appelmelk B.J., Kusomoto S., Rietschel E.T., Brade H. Characterization of the epitope specificity of murine monoclonal antibodies directed against lipid A. Infect Immun 1992; 60: 2201-2210.
62. Holst O., Brade H. The chemical structure of core oligosaccharides. In: Morrison D.C., Ryan J.L. Eds Bacterial endotoxic lipopolysaccharides, Vol 1, Molecular biochemistry and cellular biology. Boca Raton, FL, USA: CRC Press, 1992; 135-170.
63. Brade H., Rietschel E.T. α-2→4-Interlinked 3-deoxy-D-manno-octulosonic acid disaccharide: a common constituent of enterobacterial lipopolysaccharides. Eur J Biochem 1984; 145: 231-236.
64. Brade H., Zähringer U., Rietschel E.T. et al. Spectroscopic analysis of a 3-deoxy-D-manno-2-octulosonic acid (KDO) disaccharide from the lipopolysaccharide of a Salmonella godesberg Re-mutant. Carbohydr Res 1984; 134: 157-166.
65. Brade L., Holst O., Kosma P. et al. Characterization of murine monoclonal and murine, rabbit, and human polyclonal antibodies against chlamydial lipopolysaccharide. Infect Immun 1990; 58: 205-213.
66. Brade L., Kosma P., Appelmelk B.J. et al. Use of synthetic antigens to determine the epitope specificity of monoclonal antibodies against the 3-deoxy-D-manno-2-octulosonate region of bacterial lipopolysaccharide. Infect Immun 1987; 55: 462-466.
67. Rozalski A., Brade L., Kosma P. et al. Epitope specificities of murine monoclonal and rabbit polyclonal antibodies against enterobacterial lipopolysaccharides of the Re-chemotype. Infect Immun 1989; 57: 2645-2652.
68. Rozalski A., Brade L., Kuhn H-M. et al. Epitope specificities of monoclonal antibodies against the 3-deoxy-D-manno-2-octulosonate region of bacterial lipopolysaccharide. Carbohydr Res 1990; 193: 257-270.
69. Kosma P., Bahnmüller R., Schulz G. et al. Synthesis of a tetrasaccharide hapten related to the genus-specific lipopolysaccharide epitope of Chlamydia. Carbohydr Res 1990; 208: 37-50.
70. Kosma P., Schulz G., Brade H. Synthesis of a trisaccharide of 3-deoxy-D-manno-2-octulopyranosylonic acid (KDO) residues related to the genus-specific lipopolysaccharide epitope of CMamydia. Carbohydr Res 1988; 183: 183-199.
71. Kosma P., Schulz G., Unger F.M. et al. Synthesis of trisaccharides containing 3-deoxy-D-manno-2-octulosonic acid residues related to the KDO-region of enterobacterial lipopolysaccharides. Carbohydr Res 1989; 190: 191-201.
72. Kosma P., Strobl M., Allmaier G. et al. Synthesis of pentasaccharide core structures corresponding to the genus-specific lipopolysaccharide epitope of Chlamydia. Carbohydr Res 1994; 254: 105-132.
73. Caldwell H.D., Hitchcock P.J. Monoclonal antibody against a genus-specific antigen of Chlamydia species: location of the epitope on chlamydial lipopolysaccharide. Infect Immun 1984; 44: 306-314.
74. Nano F.E., Caldwell H.D. Expression of the chlamydial genus-specific lipopolysaccharide epitope in Escherichia coli. Science 1985; 228: 742-744.
75. Brade L. Nano F.E., Schlecht S. et al. Antigenic and immunogenic properties of recombinants from Salmonella typhimurium and Salmonella minnesota rough mutants expressing in their lipopolysaccharide a genus-specific epitope of Chlamydiae. Infect Immun 1987; 55: 482-486.
76. Brade H., Brade L., Nano F.E. Chemical and serological investigations on the genus-specific lipopolysaccharide epitope of Chlamydia. Proc Natl Acad Sci USA 1987; 84: 2508-2512.
77. Holst O., Brade H., Kosma P. G.l.c.-m.s. of reduced, acetylated, and methylated (2→4)- and (2→8)-linked disaccharides of 3-deoxy-D-manno-2-octulopyranosonicacid (Kdo). Carbohydr Res 1992; 231: 65-71.
78. Holst O., Brade L., Kosma P. et al. Structure, serological specificity, and synthesis of artificial glycoconjugates representing the genus-specific lipopolysaccharide epitope of Chlamydia. J Bacteriol 1991; 173: 1862-1866.
79. Holst O., Broer W., Thomas-Oates J.E. et al. Structural analysis of two oligosaccharide bisphosphates isolated from a recombinant strain of Escherichia coli F515 (Re chemotype) expressing the genus-specific epitope of Chlamydia lipopolysaccharide. Eur J Biochem 1993; 214: 703-710.
80. Holst O., Bock K., Brade L., Brade H. The structures of oligosaccharide bisphosphates isolated from the lipopolysaccharide of a recombinant Escherichia coli strain expressing the gene gseA [3-deoxy-D-manno-octulopyranosonic acid (Kdo) transferase] of Chlamydia psittaci 6BC. Eur J Biochem 1995; 229: 194-200.
81. Holst O., Thomas-Oates J.E., Brade H. Preparation and structural analysis of oligosaccharide monophosphates obtained from the lipopolysaccharides of recombinant strains of Salmonella Minnesota and Escherichia coli expressing the genus-specific epitope of Chlamydia lipopolysaccharide. Eur J Biochem 1994; 222: 183-194.
82. Fu Y., Baumann M., Kosma P. et al. A synthetic glycoconjugate representing the genus-specific epitope of chlamydial lipopolysaccharide exhibits the same immunoreactivity as its natural counterpart. Infect Immun 1992; 60: 1314-1321.
83. Mäkelä P.H., Stocker B.D.A. Genetics of lipopolysaccharide. In: Proctor R.A. Ed. Handbook of Endotoxins, Vol. 1. Amsterdam: Elsevier, 1994; 59-137.
84. Schnaitman C.A., Klena J.D. Genetics of lipopolysaccharide biosynthesis in enteric bacteria. Microbiol Rev 1993; 57: 655-682.
85. Woisetschläger M., Högenauer G. Cloning and characterization of the gene encoding 3-deoxy-D-manno-octulosonic acid 8-phosphate synthetase from Escherichia coli. J Bacteriol 1986; 168: 437-439.
86. Goldman R.C., Kohlbrenner W.E. Molecular cloning of the structural gene coding for CTP:CMP-3-deoxy-manno-octulosonate cytidyltransferase from Escherichia coli K-12. J Bacteriol 1985; 163: 256-261.
87. Woisetschläger M., Högenauer G. Cloning and characterization of the gene encoding 3-deoxy-D-manno-octulosonic acid 8-phosphate synthetase from Escherichia coli. J Bacteriol 1986; 168: 437-439.
88. Brabetz W, Brade H. Molecular cloning, sequence analysis, and functional characterization of the gene kdsA, encoding 3-deoxy-α-D-manno-octulosonate-8-phosphate synthase of Chlamydia psittaci 6BC. Eur J Biochem 1997; In press.
89. Clementz T., Raetz C.R.H. A gene coding for 3-deoxy-D-manno-octulosonic acid transferase from Escherichia coli. J Biol Chem 1991; 266: 9687-9696.
90. Belunis C.J., Mdluli K.E., Raetz C.R.H. et al. A novel 3-deoxy-D-manno-octulosonic acid transferase from Chlamydia trachomatis required for expression of the genus-specific epitope. J Biol Chem 1992; 267: 18702-18707.
91. Mamat U., Baumann M., Schmidt G. et al. The genus-specific lipopolysaccharide epitope of Chlamydia is assembled in C. psittaci and C. trachomatisby glycosyl-transferases of low homology. Mol Microbiol 1993; 10: 935-941.
92. Löbau S., Mamat U., Brabetz W., Brade H. Molecular cloning, sequence analysis, and functional characterization of the lipopolysaccharide biosynthetic gene kdtA encoding 3-deoxy-α-manno-octulosonic acid transferase of Chlamydia pneumoniae strain TW-183. Mol Microbiol 1995; 18: 391-399.
93. Karimi S.T., Schloemer R.H., Wilde III C.E. Accumulation of chlamydial lipopolysaccharide antigen in the plasma membranes of infected cells. Infect Immun 1989; 57: 1780-1785.
94. Richmond S.J., Stirling P. Localization of chlamydial group antigen in McCoy cell monolayers infected with Chlamydia trachomatis or Chlamydia psittaci. Infect Immun 1981; 34: 561-570.
95. Ingalls R.R., Rice P.A., Qureshi N., Takayama K., Lin J.S., Golenbock D.T. The inflammatory cytokine response to Chlamydia trachomatis infection is endotoxin mediated. Infect Immun 1995; 63: 3125-3130.
96. Campbell S., Richmond S.J., Yates P.S. et al. Lipopolysaccharide in cells infected by Chlamydia trachomatis. Microbiol 1994; 140: 1995-2002.
97. 2 in tissue culture. Infect Immun 1992; 60: 4433-4438.
98. Birkelund S., Lundemose A.G., Christiansen G. Immunoelectron microscopy of lipopolysaccharide in Chlamydia trachomatis. Infect Immun 1987; 57: 3250-3253.
99. Lukácová M., Baumann M., Brade L. et al. Lipopolysaccharide smooth/rough phase variation in bacteria of the genus Chlamydia. Infect Immun 1994; 62: 2270-2276.
100. Vinogradov E.V., Pantophlet R., Dijkshoorn L., Brade L., Holst O., Brade H. Structural and serological characterisation of two O-specific polysaccharides of Acinetobacter. Eur J Biochem 1996; 239: 602-610.
101. Moran A., Appelmelk B.J., Aspinall G.O. Resistance of Serratia marcescens to polymyxin B. a comparative investigation of two S-form lipopolysaccharides obtained from a sensitive and a resistant variant of strain 111. J Endotoxin Res 1996 3: 497-504.
102. Lukácová M, Kazár J., Gajdosová E., Vavreková M. Phase variation of lipopolysaccharide of Coxiella burnetii, strain Priscilla during chick embryo yolk sac passaging. FEMS Microbiol Lett 1993; 113: 285-290.
103. Cowley S.C., Myltseva S.V., Nano F.E. Phase variation in Francisella tularensis affecting intracellular growth, lipopolysaccharide antigenicity and nitric oxide production. Mol Microbiol 1996; 20: 867-874.
104. Van Putten J.P.M., Robenson B.D. Molecular mechanisms and implications for infection of lipopolysaccharide variation in Neisseria. Mol Microbiol 1995; 16: 847-853.
105. Roche R.J., High N.J., Moxon E.R. Phase variation of Haemophilus Influenzae lipopolysaccharide: Characterization of lipopolysaccharide from individual colonies. FEMS Microbiol Lett 1994; 120: 279-284.
106. Smith H., Parsons N.J., Cole J.A. Sialylation of neisserial lipopolysaccharide: a major influence on pathogenicity. Microb Pathog 1995; 19: 365-377.
107. Mandrell R.E., McLaughlin R., Kwaik Y.A. et al. Lipooligosaccharides (LOS) of some Haemophilia species mimic human glycosphingolipids, and some LOS are sialylated. Infect Immun 1992; 60: 1322-1328.
108. Mandrell R.E., Lesse A., Sugai J.V. et al. In vitro and in vivo modification of Neisseria gonorrhoeae lipooligosaccharide epitope structure by sialylation. J Exp Med 1990; 171: 1649-1664.
109. Allen A., Maskell D. The identification, cloning and mutagenesis of a genetic locus required for lipopolysaccharide biosynthesis in Bordetella pertussis. Mol Microbiol 1996; 19: 37-52.
110. Mikol V., Kosma P., Brade H. Crystal and molecular structure of allyl O-(sodium 3-deoxy-α-D-manno-2-octulopyranosylonate)-(2→8)-O-(sodium3-deoxy- α-D-manno-2-octulopyranosidonate)-monohydrate. Carbohydr Res 1994; 263: 35-42.
111. Bundle D.R., Young N.M. Carbohydrate-protein interactions in antibodies and lectins. Curr Opin Struct Biol 1992; 2: 666-673.
112. Cygler M., Rose D.R., Bundle D.R. Recognition of a cell-surface oligosaccharide of pathogenic Salmonella by an antibody fab fragment. Science 1991; 253: 442-445.
113. Brade L., Brunnemann H., Ernst M. et al. Occurrence of antibodies against chlamydial lipopolysaccharide in human sera as measured by ELISA using an artificial glycoconjugate antigen. FEMS Med Microbiol Immunol 1994; 8: 27-42.